Optimal Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Optimal Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.71M	Buy	6,137 +10	+0.2%	+$6.21K	0.46%	72
2021 Q2	$3.42M	Hold	6,127	–	–	0.41%	86
2021 Q1	$2.9M	Buy	6,127 +2,300	+60%	+$1.12M	0.38%	95
2020 Q4	$1.85M	Buy	3,827 +1	+0%	+$540	0.26%	132
2020 Q3	$2.14M	Buy	3,826 +783	+26%	+$475K	0.31%	105
2020 Q2	$1.9M	Sell	3,043 -1,792	-37%	-$1.02M	0.31%	117
2020 Q1	$2.36K	Buy	4,835 +2,216	+85%	+$914K	0.22%	155
2019 Q4	$983K	Buy	+2,619	New	+$881K	0.15%	242

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Optimal Asset Management's REGN Position: Q3 2021 in Review

Optimal Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.16% in Q3 2021, buying an estimated $6.21K and bringing the position to 6,137 shares worth $3.71M. The position accounts for 0.46% of the portfolio, ranked #72.

Optimal Asset Management first reported a position in REGN in Q4 2019 and has held it in 8 quarters since. 1,017 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

Optimal Asset Management held 6,137 shares of Regeneron Pharmaceuticals worth $3.71M as of Q3 2021.
Optimal Asset Management bought 10 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $6.21K.
Regeneron Pharmaceuticals made up 0.46% of Optimal Asset Management's portfolio in Q3 2021, its #72 holding.
Optimal Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
1,017 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.